Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123049113 | 12304911 | 3 | F | 2010 | 20160614 | 20160426 | 20160707 | PER | US-PFIZER INC-2016188834 | PFIZER | 57.00 | YR | F | Y | 0.00000 | 20160707 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123049113 | 12304911 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | UNK | 20235 | |||||||||||
123049113 | 12304911 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, 2X/DAY | 20235 | 600 | MG | BID | ||||||||
123049113 | 12304911 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | 1200 MG, 1X/DAY NIGHTLY | 20235 | 1200 | MG | QD | ||||||||
123049113 | 12304911 | 4 | C | DICLOFENAC | DICLOFENAC | 1 | 75 MG, 2X/DAY | 0 | 75 | MG | BID | ||||||||
123049113 | 12304911 | 5 | C | ROBAXIN | METHOCARBAMOL | 1 | 500 MG, 3X/DAY | 0 | 500 | MG | TABLET | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123049113 | 12304911 | 1 | Fibromyalgia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123049113 | 12304911 | Drug ineffective for unapproved indication |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123049113 | 12304911 | 2 | 20160308 | 0 | ||
123049113 | 12304911 | 5 | 201604 | 0 |